1. Home
  2. NTRA vs RJF Comparison

NTRA vs RJF Comparison

Compare NTRA & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.35

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Logo Raymond James Financial Inc.

RJF

Raymond James Financial Inc.

HOLD

Current Price

$152.28

Market Cap

32.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
RJF
Founded
2003
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
32.5B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
RJF
Price
$197.35
$152.28
Analyst Decision
Strong Buy
Hold
Analyst Count
14
11
Target Price
$259.07
$182.91
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
1.38%
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$16.65
$14.81
Revenue Next Year
$19.22
$8.22
P/E Ratio
N/A
$15.77
Revenue Growth
N/A
N/A
52 Week Low
$125.38
$118.57
52 Week High
$256.36
$177.66

Technical Indicators

Market Signals
Indicator
NTRA
RJF
Relative Strength Index (RSI) 36.47 38.91
Support Level $195.46 $151.36
Resistance Level $251.09 $170.97
Average True Range (ATR) 8.23 4.09
MACD -0.65 -0.23
Stochastic Oscillator 17.11 15.20

Price Performance

Historical Comparison
NTRA
RJF

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About RJF Raymond James Financial Inc.

Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.

Share on Social Networks: